Group structure
16 companies in 6 countries
Loading…
16 companies in 6 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
1–25 of 150
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ACARBOSE TABLETS100 mg · Tablet | Acarbose | Canada | Not marketed | 2020 |
| ACARBOSE TABLETS50 mg · Tablet | Acarbose | Canada | Not marketed | 2020 |
| ACCOLATE10mg | 20mg · Tablet | Zafirlukast | United States | Marketed | 1996 |
| ACIDOS OMEGA 3 STRIDES 1000 MG CAPSULAS BLANDAS EFG1000 mg · Cápsula blanda | Acidos omega esteres etilicos | Spain | Marketed | 2014 |
| ALFACALCIDOL CAPSULES1 mcg · Capsule | Alfacalcidol | Canada | Authorised | |
| ALFACALCIDOL CAPSULES0.25 mcg · Capsule | Alfacalcidol | Canada | Authorised | |
| Alfacalcidol Strides Pharma 0,25 microgram, zachte capsulesCapsule, zacht | Alfacalcidol | Netherlands | Authorised | 2018 |
| Alfacalcidol Strides Pharma 0,5 microgram, zachte capsulesCapsule, zacht | Alfacalcidol | Netherlands | Authorised | 2018 |
| Alfacalcidol Strides Pharma 1 microgram, zachte capsulesCapsule, zacht | Alfacalcidol | Netherlands | Authorised | 2018 |
| ALLERGY RELIEF CETIRIZINE HYDROCHLORIDE LIQUID GELS10 mg · Capsule (Immediate-Release) | Cetirizine | Canada | Authorised | |
| Amitriptyline HCl Strides 10 mg filmomhulde tablettenFilmomhulde tablet | Amitriptyline | Netherlands | Authorised | 2020 |
| Amitriptyline HCl Strides 25 mg filmomhulde tablettenFilmomhulde tablet | Amitriptyline | Netherlands | Authorised | 2020 |
| Amitriptyline HCl Strides 50 mg filmomhulde tablettenFilmomhulde tablet | Amitriptyline | Netherlands | Authorised | 2020 |
| AMITRIPTYLINE HYDROCHLORIDE TABLETS USP25 mg · Tablet | Amitriptyline | Canada | Authorised | |
| AMITRIPTYLINE HYDROCHLORIDE TABLETS USP50 mg · Tablet | Amitriptyline | Canada | Authorised | |
| AMITRIPTYLINE HYDROCHLORIDE TABLETS USP75 mg · Tablet | Amitriptyline | Canada | Authorised | |
| AMITRIPTYLINE HYDROCHLORIDE TABLETS USP10 mg · Tablet | Amitriptyline | Canada | Authorised | |
| AMLODIPINE BESYLATE AND VALSARTAN10mg base; 160mg | 10mg base; 320mg | 5mg base; 160mg | 5mg base; 320mg · Tablet | Amlodipine, Valsartan | United States | Marketed | 2013 |
| AMLODIPINE BESYLATE, VALSARTAN AND HYDROCHLOROTHIAZIDE10mg base; 12.5mg; 160mg | 10mg base; 25mg; 160mg | 10mg base; 25mg; 320mg | 5mg base; 12.5mg; 160mg | 5mg base; 25mg; 160mg · Tablet | Amlodipine, Hydrochlorothiazide, Valsartan | United States | Marketed | 2012 |
| ATOMOXETINE HYDROCHLORIDE100mg | 100mg base | 10mg | 10mg base | 18mg | 18mg base | 25mg | 25mg base | 40mg | 40mg base | 60mg | 60mg base | 80mg | 80mg base · Capsule | Atomoxetine | United States | Marketed | 2010 |
| AZITHROMYCIN FOR INJECTION, USP500 mg / vial · Powder For Solution | Azithromycin | Canada | Authorised | |
| BUSPIRONE HYDROCHLORIDE TABLETS, USP10 mg · Tablet | Buspirone | Canada | Authorised | |
| CARBOPLATIN INJECTION, BP10 mg / ml · Solution | Carboplatin | Canada | Authorised | |
| CISPLATIN INJECTION1 mg / ml · Solution | Cisplatin | Canada | Authorised | |
| Citalopram Strides 40 mg/ml druppels voor oraal gebruik, oplossingDruppels voor oraal gebruik, oplossing | Citalopram | Netherlands | Authorised | 2019 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 63 | 51 | 12 | CompaniesAll medicines |
| Netherlands | 31 | 31 | 0 | CompaniesAll medicines |
| United States | 31 | 20 | 11 | CompaniesAll medicines |
| Singapore | 15 | 15 | 0 | CompaniesAll medicines |
| Spain | 9 | 9 | 0 | CompaniesAll medicines |
| European Union (EMA) | 1 | 1 | 0 | CompaniesAll medicines |
Also in the registers of Brazil, Colombia, Italy, Malaysia, Sweden, United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM otros; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vencidos; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vigentes; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; https://www.gov.uk/government/publications/marketing-authorisations-granted-in-2026; publication updated 7 October 2026; source PDF periods January–September 2026; original bytes acquired 18 October 2026; PDF page/table/exact-authorisation projections by Prognia under OGL v3.0.
Licence: Open Government Licence v3.0; GOV.UK Crown copyright publication and linked factual MHRA grant registers
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
National Pharmaceutical Regulatory Agency and Ministry of Health Malaysia, KKMNOW Approved Pharmaceutical Products, https://data.moh.gov.my/data-catalogue/pharmaceutical_products; CC BY 4.0; original data as of 2026-09-30 23:59; acquired 2026-10-16T22:34:39.948031+00:00; Prognia preserves original records and projects exact MAL IDs and category/role fields. No government endorsement implied.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0), exact MOH dataset dedication
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Läkemedelsverket, Sweden, Förvaringstemperatur och hållbarhet, source extract 2026-10-20, acquired 2026-10-20T20:46:08.868635+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Läkemedelsverket, Sweden, Läkemedelsprodukter, source extract 2026-10-20, acquired 2026-10-20T20:45:53.483733+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Contains information from ACRA Information on Corporate Entities, accessed on 8 October 2026 through Data.gov.sg, under Singapore Open Data Licence version 1.0: https://data.gov.sg/open-data-licence. Structured selection and normalisation by Prognia; original UEN, field and retrieval date retained.
Licence: Singapore Open Data Licence
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
Report an error or request removalCorrections from the company itself are welcome.
Keep Strides’s medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a callWell-known pharmaceutical groups, each with all its companies.